Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−2.1 DKK
−12.10 M DKK
5.58 M DKK
3.20 M
About VIROGATES A/S
Sector
Industry
CEO
Jakob Knudsen
Website
Headquarters
Birkerod
Founded
2000
ISIN
DK0061030574
FIGI
BBG00L2R5H35
ViroGates A/S develops and markets prognostic products for the healthcare sector. Its products include suPARnostic TurbiLatex, suPARnostic Quick Triage, and suPARnostic ELISA. The products of the company are used for the prognosis of lifestyle-related diseases, such as cardiovascular disease, type 2 diabetes, cancer, and emergency services to make a clinical decision on hospitalization or discharge of acute medical patients. The company was founded by Jesper Eugen-Olsen, Jørgen Axel Thorball, and Peter James Arthur Benson in 2001 and is headquartered in Birkerod, Denmark.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VIRO is 16.5 DKK — it has increased by 7.38% in the past 24 hours. Watch VIROGATES A/S stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXCOP exchange VIROGATES A/S stocks are traded under the ticker VIRO.
VIRO stock has fallen by −29.20% compared to the previous week, the month change is a 146.15% rise, over the last year VIROGATES A/S has showed a 164.18% increase.
VIRO reached its all-time high on May 5, 2021 with the price of 194.3 DKK, and its all-time low was 5.0 DKK and was reached on Dec 21, 2023. View more price dynamics on VIRO chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VIRO stock is 18.06% volatile and has beta coefficient of −0.84. Track VIROGATES A/S stock price on the chart and check out the list of the most volatile stocks — is VIROGATES A/S there?
Today VIROGATES A/S has the market capitalization of 123.75 M, it has increased by 12.68% over the last week.
Yes, you can track VIROGATES A/S financials in yearly and quarterly reports right on TradingView.
VIROGATES A/S is going to release the next earnings report on Mar 19, 2025. Keep track of upcoming events with our Earnings Calendar.
VIRO net income for the last quarter is −2.23 M DKK, while the quarter before that showed −4.09 M DKK of net income which accounts for 45.58% change. Track more VIROGATES A/S financial stats to get the full picture.
No, VIRO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 21, 2024, the company has 10.00 employees. See our rating of the largest employees — is VIROGATES A/S on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. VIROGATES A/S EBITDA is −13.13 M DKK, and current EBITDA margin is −224.38%. See more stats in VIROGATES A/S financial statements.
Like other stocks, VIRO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIROGATES A/S stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VIROGATES A/S technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VIROGATES A/S stock shows the buy signal. See more of VIROGATES A/S technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.